Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vishalakshi Krishnan

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Molecular Biology|March 1, 2011
Viral RNAi suppressor reversibly binds siRNA to outcompete Dicer and RISC via multiple turnoverRenata A Rawlings, Vishalakshi Krishnan, Nils G Walter
Methods (San Diego, Calif.)|July 4, 2013
Dissecting non-coding RNA mechanisms in cellulo by Single-molecule High-Resolution Localization and CountingSethuramasundaram Pitchiaya, Vishalakshi Krishnan, Thomas C Custer, et al.
Plos One|June 8, 2011
siRNA-like double-stranded RNAs are specifically protected against degradation in human cell extractJohn A H Hoerter, Vishalakshi Krishnan, Troy A Lionberger, et al.
Pharmaceutical Research|December 24, 2021
Research and Education Needs for Complex GenericsSydney Stern, Jill Coghlan, Vishalakshi Krishnan, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 11, 2023
Regulatory utility of mechanistic modeling to support alternative bioequivalence approaches: A workshop overviewAndrew Babiskin, Fang Wu, Youssef Mousa, et al.
The AAPS Journal|April 24, 2024
Application of Advanced Modeling Approaches Supporting Generic Product Development Under GDUFA for Fiscal Year 2023Eleftheria Tsakalozou, Yuqing Gong, Andrew Babiskin, et al.
AAPS Open|April 23, 2026
Mastering particle size analysis: lessons, challenges, and future directions from the FDA-CRCG workshopXiaoming Xu, William C Smith, James E Polli, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Molecular Biology|March 1, 2011
Viral RNAi suppressor reversibly binds siRNA to outcompete Dicer and RISC via multiple turnoverRenata A Rawlings, Vishalakshi Krishnan, Nils G Walter
Methods (San Diego, Calif.)|July 4, 2013
Dissecting non-coding RNA mechanisms in cellulo by Single-molecule High-Resolution Localization and CountingSethuramasundaram Pitchiaya, Vishalakshi Krishnan, Thomas C Custer, et al.
Plos One|June 8, 2011
siRNA-like double-stranded RNAs are specifically protected against degradation in human cell extractJohn A H Hoerter, Vishalakshi Krishnan, Troy A Lionberger, et al.
Pharmaceutical Research|December 24, 2021
Research and Education Needs for Complex GenericsSydney Stern, Jill Coghlan, Vishalakshi Krishnan, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 11, 2023
Regulatory utility of mechanistic modeling to support alternative bioequivalence approaches: A workshop overviewAndrew Babiskin, Fang Wu, Youssef Mousa, et al.
The AAPS Journal|April 24, 2024
Application of Advanced Modeling Approaches Supporting Generic Product Development Under GDUFA for Fiscal Year 2023Eleftheria Tsakalozou, Yuqing Gong, Andrew Babiskin, et al.
AAPS Open|April 23, 2026
Mastering particle size analysis: lessons, challenges, and future directions from the FDA-CRCG workshopXiaoming Xu, William C Smith, James E Polli, et al.
Pageof 1